GSK plc Share Purchase Report

On March 9, 2026, GSK plc executed a share buyback program, purchasing 516,000 ordinary shares through its broker, BNP Paribas SA. The transactions occurred on the London Stock Exchange and CBOE Europe Limited. The volume-weighted average price paid per share was 2,028.51p, with prices ranging from 1,989.00p to 2,047.00p. These repurchased shares will be held as treasury shares. This activity is part of the company's ongoing buyback program, initiated on February 17, 2026. Following this purchase, GSK plc holds 247,563,094 ordinary shares in treasury, with 4,068,605,728 ordinary shares in issue. The total voting rights remain at 4,068,605,728, and the percentage of voting rights held in treasury is 6.08%.